Training scientists to develop innovative solutions for drug addiction
Program on Entrepreneurship and Innovation for Biomedical Product Development (EI4BPD)
This study is helping scientists learn how to turn their ideas into real solutions for drug addiction, so they can create better ways to prevent and treat substance use disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11103157 on NIH RePORTER |
What this research studies
This program focuses on addressing the drug addiction epidemic in the U.S. by training life science researchers in entrepreneurship and biomedical product development. It aims to create effective prevention, diagnostic, and treatment solutions for substance use disorders (SUDs) through a customized curriculum. Over four years, 15 fellows will be selected annually to participate in a comprehensive educational program that includes both online and in-person training, guided by experts from various fields. The goal is to equip these scientists with the skills needed to bring their innovative technologies from the lab to the market.
Who could benefit from this research
Good fit: Ideal candidates for participation would be U.S. scientists engaged in research related to substance use disorders.
Not a fit: Patients who are not involved in scientific research or do not have a background in life sciences may not benefit directly from this program.
Why it matters
Potential benefit: If successful, this research could lead to the development of groundbreaking technologies that improve prevention and treatment options for individuals struggling with substance use disorders.
How similar studies have performed: While the approach of training researchers in entrepreneurship is innovative, similar educational programs have shown success in other biomedical fields.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Breazeal, Cynthia — Massachusetts Institute of Technology
- Study coordinator: Breazeal, Cynthia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.